# Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea

> **NCT01964950** · — · COMPLETED · sponsor: **Takeda** · enrollment: 1101 (actual)

## Conditions studied

- Surveillance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01964950
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 1101 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964950, "Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01964950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*